SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-24-000021
Filing Date
2024-01-08
Accepted
2024-01-08 16:05:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2973
  Complete submission text file 0001973141-24-000021.txt   4457
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37766 | Film No.: 24520058
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130 CAMBRIDGE MA 02139
Business Address
Sepp-Lorenzino Laura (Reporting) CIK: 0001777421 (see all company filings)

Type: 144